# ![@GRI_BIO Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1012760030997893120.png) @GRI_BIO GRI Bio, Inc.

GRI Bio, Inc. posts on X about $gri, hertz, ceo, $vlon the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::1012760030997893120/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1012760030997893120/c:line/m:interactions.svg)

- [--] Week [---] +10%
- [--] Month [-----] -45%
- [--] Months [------] -75%
- [--] Year [-------] +1,131%

### Mentions: [--] [#](/creator/twitter::1012760030997893120/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1012760030997893120/c:line/m:posts_active.svg)

- [--] Months [--] -36%
- [--] Year [--] +286%

### Followers: [-----] [#](/creator/twitter::1012760030997893120/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1012760030997893120/c:line/m:followers.svg)

- [--] Week [-----] +0.04%
- [--] Month [-----] +0.53%
- [--] Months [-----] +6%
- [--] Year [-----] +5.80%

### CreatorRank: [---------] [#](/creator/twitter::1012760030997893120/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1012760030997893120/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  26.42% [finance](/list/finance)  12.26% [travel destinations](/list/travel-destinations)  0.94%

**Social topic influence**
[$gri](/topic/$gri) 74.53%, [hertz](/topic/hertz) 25.47%, [ceo](/topic/ceo) 10.38%, [$vlon](/topic/$vlon) #1, [bio](/topic/bio) 7.55%, [virtual](/topic/virtual) 5.66%, [in the](/topic/in-the) 4.72%, [we are](/topic/we-are) 3.77%, [cascade](/topic/cascade) 3.77%, [study](/topic/study) 3.77%

**Top accounts mentioned or mentioned by**
[@investorvirtual](/creator/undefined) [@hcwco](/creator/undefined) [@aacvpr](/creator/undefined) [@atscommunity](/creator/undefined) [@webullglobal](/creator/undefined) [@hansonwade](/creator/undefined) [@keckschoolusc](/creator/undefined) [@lupusorg](/creator/undefined) [@pfforg](/creator/undefined)

**Top assets mentioned**
[Hertz Global Holdings, Inc Common Stock (HTZ)](/topic/hertz) [Aardvark Therapeutics, Inc (AARD)](/topic/$aard)
### Top Social Posts
Top posts by engagements in the last [--] hours

"We proudly welcome the new year with a new look. Check out our new website at #ADHD #Narcolepsy #StimulantAbuse #AbuseDeterrent http://www.vallon-pharma.com http://www.vallon-pharma.com"  
[X Link](https://x.com/GRI_BIO/status/1349789230743089154)  2021-01-14T18:43Z [----] followers, [--] engagements


"$VLON is presenting today at the @HCWCO Global Life Sciences Conference. To watch the webcast click here: #AbuseDeterrent #ADHD #CNSDisorders http://bit.ly/3rzKbSf#HCWEvents http://bit.ly/3rzKbSf#HCWEvents"  
[X Link](https://x.com/GRI_BIO/status/1369298913379942418)  2021-03-09T14:47Z [----] followers, [--] engagements


"As part of #NDAFW we invite you to learn about our platform technology. With the intent to potentially lower #StimulantAbuse ADAIR is designed to deter intranasal and/or intravenous abuse. $VLON #ADHD #AbuseDeterrent http://bit.ly/37HT9oy http://bit.ly/37HT9oy"  
[X Link](https://x.com/GRI_BIO/status/1374774992873865222)  2021-03-24T17:27Z [----] followers, [--] engagements


"Prescription stimulant abuse represents a significant problem particularly among teenagers and young adults. #prescriptionabuse #stimulantabuse $VLON"  
[X Link](https://x.com/GRI_BIO/status/1405552322550304778)  2021-06-17T15:46Z [----] followers, [--] engagements


"40% of people who abuse or misuse prescription stimulants report snorting or injecting them. #StimulantAbuse #AbuseDeterrent $VLON"  
[X Link](https://x.com/GRI_BIO/status/1418280778945925121)  2021-07-22T18:44Z [----] followers, [--] engagements


"$VLON #2021ScorecardSeries: July [--] 2021: Announced Issuance of New European Patent Covering Method of Use and Composition of Matter for ADAIR #ADHD #ADHDAwareness #StimulantAbuse https://bit.ly/3cdgVL0 https://bit.ly/3cdgVL0"  
[X Link](https://x.com/GRI_BIO/status/1470822486552023049)  2021-12-14T18:26Z [----] followers, [--] engagements


"We are a clinical-stage biopharmaceutical company focused on developing novel abuse-deterrent medications for CNS disorders. $VLON #ADHD #ADHDAwareness #StimulantAbuse @InvestorVirtual #VirtualInvestor"  
[X Link](https://x.com/GRI_BIO/status/1481290954640351235)  2022-01-12T15:44Z [----] followers, [--] engagements


"In [----] we prioritized disciplined clinical execution and balance sheet strength delivering compelling clinical data from our lead IPF program which underscores the therapeutic differentiation of GRI-0621 said Marc Hertz PhD $GRI CEO. For recent highlights: https://bit.ly/4awq6Fe https://bit.ly/4awq6Fe"  
[X Link](https://x.com/GRI_BIO/status/2019126412725108786)  2026-02-04T19:10Z [----] followers, [---] engagements


"Tune-in on Wednesday February 11th at 1:00 PM EST for our CEO Marc Hertz PhD's presentation during the Corporate Connect Webinar Series hosted by Webull Financial. Register here: $GRI https://bit.ly/4rpzK20 https://bit.ly/4rpzK20"  
[X Link](https://x.com/GRI_BIO/status/2020913199697072147)  2026-02-09T17:30Z [----] followers, [---] engagements


"Reminder: Join us today February 11th at 1:00 PM EST for GRI Bio CEO Marc Hertz PhD's presentation during the Corporate Connect Webinar Series hosted by Webull Financial. For webcast details: $GRI https://bit.ly/4rpzK20 https://bit.ly/4rpzK20"  
[X Link](https://x.com/GRI_BIO/status/2021592672176148506)  2026-02-11T14:30Z [----] followers, [---] engagements


"GRI Bio Inc. to Participate in the Virtual Investor Summer Spotlight Series. $GRI @InvestorVirtual #NKT #IdiopathicPulmonaryFibrosis #SystemicLupusErythematosus"  
[X Link](https://x.com/GRI_BIO/status/1724092148633784772)  2023-11-13T15:49Z [----] followers, 378.2K engagements


"We are advancing an innovative pipeline of #NKT cell modulators for the treatment of #inflammatory #fibrotic and #autoimmune diseases. $GRI #IdiopathicPulmonaryFibrosis #SystemicLupusErythematosus"  
[X Link](https://x.com/GRI_BIO/status/1724092309376245967)  2023-11-13T15:50Z [----] followers, 128.6K engagements


"We target earlier key steps in the inflammatory cascade to interrupt disease progression. $GRI #NKT #IdiopathicPulmonaryFibrosis #SystemicLupusErythematosus"  
[X Link](https://x.com/GRI_BIO/status/1724092309401432144)  2023-11-13T15:50Z [----] followers, 151.8K engagements


"Our CEO Marc Hertz PhD provides insight to how we are developing #NKT cells for #immuneregulation. Watch the full video here: $GRI #AutoimmuneDisease #InflammatoryDisease #IdiopathicPulmonaryFibrosis #SystemicLupusErythematosus"  
[X Link](https://x.com/GRI_BIO/status/1724092309413998607)  2023-11-13T15:50Z [----] followers, 28.2K engagements


"Our CEO Dr. Marc Hertz highlights our novel approach to #immunemodulation. Watch the full video here: $GRI #NKT #AutoimmuneDisease #InflammatoryDisease #FibroticDisease"  
[X Link](https://x.com/GRI_BIO/status/1732402084211794425)  2023-12-06T14:10Z [----] followers, [---] engagements


"Dr. Marc Hertz CEO of $GRI speaks to why we are targeting #IPF. Watch the full video here: #NKT #AutoimmuneDisease #InflammatoryDisease #FibroticDisease"  
[X Link](https://x.com/GRI_BIO/status/1735321282948784517)  2023-12-14T15:30Z [----] followers, [--] engagements


"CEO of $GRI Dr. Marc Hertz provides color to our approach of targeting the activity of #NKT cells which are key regulators earlier in the inflammatory cascade. Watch the full video here: #NKT #AutoimmuneDisease #InflammatoryDisease #FibroticDisease"  
[X Link](https://x.com/GRI_BIO/status/1737875041289695386)  2023-12-21T16:37Z [----] followers, [---] engagements


"GRI Bio Announces Pricing of $5.5 Million Public Offering. $GRI #NKT #AutoimmuneDisease #FibroticDisease #PulmonaryDisease"  
[X Link](https://x.com/GRI_BIO/status/1753419289938317493)  2024-02-02T14:05Z [----] followers, [---] engagements


"GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent. $GRI #NKT #InflammatoryDisease #AutoimmuneDisease #FibroticDisease https://bit.ly/3Q6nLX3 https://bit.ly/3Q6nLX3"  
[X Link](https://x.com/GRI_BIO/status/1780233445970444590)  2024-04-16T13:55Z [----] followers, [---] engagements


"#TuneIn to hear our CEO Marc Hertz PhD highlight our recent clinical developments. $GRI @investorvirtual #NKT #FibroticDisease #PulmonaryDisease #AutoimmuneDisease https://vimeo.com/949291153/8fbe23c030 https://vimeo.com/949291153/8fbe23c030"  
[X Link](https://x.com/GRI_BIO/status/1793652270917169402)  2024-05-23T14:36Z [----] followers, [---] engagements


"We are proud to support Pride month"  
[X Link](https://x.com/GRI_BIO/status/1798724844017570102)  2024-06-06T14:33Z [----] followers, [--] engagements


"Did you see our recent #CEOConnect with Virtual Investor Check it out here: $GRI @investorvirtual #VirtualInvestor #NKT #AutoimmuneDisease #FibroticDisease #PulmonaryDisease https://vimeo.com/949291153/8fbe23c030 https://vimeo.com/949291153/8fbe23c030"  
[X Link](https://x.com/GRI_BIO/status/1799066110181916949)  2024-06-07T13:09Z [----] followers, [---] engagements


"GRI Bio Announces Pricing of $4 Million Public Offering. $GRI #AutoimmuneDisease #PulmonaryFibrosis #FibroticDisease https://bit.ly/4buni9a https://bit.ly/4buni9a"  
[X Link](https://x.com/GRI_BIO/status/1806324891571957911)  2024-06-27T13:53Z [----] followers, [--] engagements


"GRI Bio Announces Closing of $4.0 Million Public Offering. $GRI https://bit.ly/3VHqbxn https://bit.ly/3VHqbxn"  
[X Link](https://x.com/GRI_BIO/status/1807395818573361319)  2024-06-30T12:48Z [----] followers, [---] engagements


"Easily stay in the know with instant updates from us Sign up here: $GRI #NKT #fibroticdisease #autoimmunedisease https://bit.ly/45GwuVq https://bit.ly/45GwuVq"  
[X Link](https://x.com/GRI_BIO/status/1813946656506744931)  2024-07-18T14:39Z [----] followers, [---] engagements


"We have an array of scientific presentations and publications that we encourage you check out $GRI #NKT #idiopathicpulmonaryfibrosis #systemiclupuserythematosus https://bit.ly/3OhuOf8 https://bit.ly/3OhuOf8"  
[X Link](https://x.com/GRI_BIO/status/1818297771603972509)  2024-07-30T14:49Z [----] followers, [----] engagements


"Have you seen our latest #WhatThisMeans segment CEO of GRI Marc Hertz PhD underscores the importance of our upcoming interim data readout of our Phase 2a biomarker study. $GRI #IdiopathicPulmonaryFibrosis https://bit.ly/3Wh9z0K https://bit.ly/3Wh9z0K"  
[X Link](https://x.com/GRI_BIO/status/1821910808420311134)  2024-08-09T14:06Z [----] followers, [---] engagements


"Email alerts are an easy way to stay up to date on our latest news events and filings Sign up here: $GRI #AutoimmuneDisease #FibroticDisease #InflammatoryDisease https://bit.ly/45GwuVq https://bit.ly/45GwuVq"  
[X Link](https://x.com/GRI_BIO/status/1824132635427213802)  2024-08-15T17:14Z [----] followers, [---] engagements


"$GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis. #NKT #IPF #FibroticDisease https://bit.ly/3zYseGw https://bit.ly/3zYseGw"  
[X Link](https://x.com/GRI_BIO/status/1846564346005950856)  2024-10-16T14:50Z [----] followers, [---] engagements


"#JoinUs Thursday December [--] [----] at 4:00 PM ET for a Virtual Investor Closing Bell Series. CEO Marc Hertz will provide key insights into the company's progress and future outlook. Register here//bit.ly/41xFDRn $GRI #NKT #FibroticDisease @InvestorVirtual"  
[X Link](https://x.com/GRI_BIO/status/1866543511354454322)  2024-12-10T18:00Z [----] followers, [---] engagements


"#JoinUs Thursday December [--] [----] at 4:00 PM ET for a Virtual Investor Closing Bell Series. CEO Marc Hertz will provide key insights into the company's progress and future outlook. Register here: $GRI #NKT #FibroticDisease @InvestorVirtual https://bit.ly/41xFDRn https://bit.ly/41xFDRn"  
[X Link](https://x.com/GRI_BIO/status/1866543777415868616)  2024-12-10T18:01Z [----] followers, [---] engagements


"#PRWeek2025 kicks off today This week highlights the role of #PulmonaryRehabilitation in improving the lives of those with lung disease. We honor rehabilitation therapists and emphasize the need for more research and support. @AACVPR $GRI #LungDisease https://bit.ly/3CN2ONw https://bit.ly/3CN2ONw"  
[X Link](https://x.com/GRI_BIO/status/1899090486054285709)  2025-03-10T13:30Z [----] followers, [--] engagements


"GRI Bio Regains Compliance with Nasdaqs Minimum Bid Price Rule $GRI #FibroticDisease #IdiopathicPulmonaryFibrosis https://bit.ly/43zT1oU https://bit.ly/43zT1oU"  
[X Link](https://x.com/GRI_BIO/status/1899445741115814264)  2025-03-11T13:02Z [----] followers, [---] engagements


"We have a library of publications showcasing our promising data in developing potential treatments for fibrotic diseases. Check it out//bit.ly/3OhuOf8 $GRI #IPF #FibroticDisease #IdiopathicPulmonaryFibrosis"  
[X Link](https://x.com/GRI_BIO/status/1900550243621405100)  2025-03-14T14:11Z [----] followers, [--] engagements


"GRI Bio Reports Full Year [----] Financial Results and Reiterates Expected Clinical Data Readouts in [----] for Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (IPF) $GRI #IPF #FibroticDisease #IdiopathicPulmonaryFibrosis https://bit.ly/4hfh3sE https://bit.ly/4hfh3sE"  
[X Link](https://x.com/GRI_BIO/status/1901627674100904151)  2025-03-17T13:32Z [----] followers, [---] engagements


"Sign up today Stay informed with our email alerts and get the latest news and updates. $GRI #IPF #FibroticDisease #IdiopathicPulmonaryFibrosis https://bit.ly/45GwuVq https://bit.ly/45GwuVq"  
[X Link](https://x.com/GRI_BIO/status/1904897657710981616)  2025-03-26T14:06Z [----] followers, [---] engagements


"Marc Hertz CEO shared early results for GRI-0621 highlighting its strong safety profile and potential to offer a better treatment for #IPF. The team is focused on advancing the study with topline data expected in Q3 [----]. $GRI #FibroticDisease https://bit.ly/4iNkfgv https://bit.ly/4iNkfgv"  
[X Link](https://x.com/GRI_BIO/status/1907078756058992697)  2025-04-01T14:33Z [----] followers, [---] engagements


"GRI Bio Announces Closing of $5.0 Million Public Offering $GRI #IPF #FibroticDisease #IdiopathicPulmonaryFibrosis https://bit.ly/3FMv442 https://bit.ly/3FMv442"  
[X Link](https://x.com/GRI_BIO/status/1907535010422280240)  2025-04-02T20:46Z [----] followers, [---] engagements


"#DidYouSee: We recently reported interim 2-Week safety results from our ongoing Phase 2a study evaluating GRI-0621. Dive into the full details here: $GRI #FibroticDisease https://bit.ly/4iNkfgv https://bit.ly/4iNkfgv"  
[X Link](https://x.com/GRI_BIO/status/1909239537294860365)  2025-04-07T13:39Z [----] followers, [---] engagements


"Living with #IdiopathicPulmonaryFibrosis can be challenging every day. Thats why were exploring new treatment options through our clinical study. Find out more here: $GRI #FibroticDisease #IPF https://bit.ly/4iWMjyd https://bit.ly/4iWMjyd"  
[X Link](https://x.com/GRI_BIO/status/1910699795057885604)  2025-04-11T14:21Z [----] followers, [---] engagements


"We are focused on fundamentally changing the way inflammatory fibrotic and autoimmune diseases are treated. $GRI #FibroticDisease #IPF"  
[X Link](https://x.com/GRI_BIO/status/1911772201142853827)  2025-04-14T13:23Z [----] followers, [---] engagements


"We are dedicated to advancing new therapies through innovative approaches for the treatment of inflammatory fibrotic and autoimmune diseases. Explore our clinical study in #IPF and see how you can help shape the future of care. $GRI #FibroticDisease http://www.gribio.com/IPFtrial http://www.gribio.com/IPFtrial"  
[X Link](https://x.com/GRI_BIO/status/1917223124874993951)  2025-04-29T14:23Z [----] followers, [---] engagements


"GRI Bios Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (IPF) $GRI #FibroticDisease #IPF #IdiopathicPulmonaryFibrosis https://bit.ly/3Sp7v42 https://bit.ly/3Sp7v42"  
[X Link](https://x.com/GRI_BIO/status/1920472894611550512)  2025-05-08T13:36Z [----] followers, [---] engagements


"Exciting news Our abstract will be presented at the [----] ATS Conference. #JoinUs on Wednesday May [--] from 8:15-10:15 AM PT in the Moscone Center for a discussion on how inactivation of iNKT cells impacts fibrosis in pulmonary fibrosis. See you there #ATS2025 @atscommunity"  
[X Link](https://x.com/GRI_BIO/status/1922665527979147768)  2025-05-14T14:49Z [----] followers, [---] engagements


"GRI Bio Reports First Quarter [----] Financial Results and Confirms GRI-0621 Phase 2a IPF Trial on Track for 6-Week Interim Data in Q2 [----] and Topline Data in Q3 [----] $GRI #FibroticDisease #IPF #IdiopathicPulmonaryFibrosis https://bit.ly/3S8kgQy https://bit.ly/3S8kgQy"  
[X Link](https://x.com/GRI_BIO/status/1923013021393199339)  2025-05-15T13:50Z [----] followers, [---] engagements


"GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase $GRI #FibroticDisease #IPF #IdiopathicPulmonaryFibrosis https://bit.ly/4kms119 https://bit.ly/4kms119"  
[X Link](https://x.com/GRI_BIO/status/1923375055725101565)  2025-05-16T13:48Z [----] followers, [---] engagements


"#MarkYourCalendars Dont miss our Fireside Chat at the AGP Healthcare Conference on Tuesday May [--] at 2:40 PM ET. Well be diving into key insights and whats ahead for $GRI. #FibroticDisease #IdiopathicPulmonaryFibrosis https://bit.ly/42X9Zg7 https://bit.ly/42X9Zg7"  
[X Link](https://x.com/GRI_BIO/status/1924476772243951946)  2025-05-19T14:46Z [----] followers, [---] engagements


"GRI Bio Presents Positive Pre-Clinical Data Demonstrating GRI-0621 Resolves Inflammation and Fibrosis in Bleomycin-Induced Fibrosis and Reiterates Promising Preliminary Phase 2a Clinical Results $GRI #FibroticDisease #IPF #IdiopathicPulmonaryFibrosis https://bit.ly/43m0dDq https://bit.ly/43m0dDq"  
[X Link](https://x.com/GRI_BIO/status/1925548222082142214)  2025-05-22T13:44Z [----] followers, [---] engagements


"#TuneInTomorrow at [--] PM ET $GRI CEO Dr. Marc Hertz live in a #VirtualInvestor Closing Bell segment. Hell dive into NKT cell innovation and answer your questions live. Dont miss out: #FibroticDisease #IdiopathicPulmonaryFibrosis @investorvirtual https://bit.ly/4khyx9u https://bit.ly/4khyx9u"  
[X Link](https://x.com/GRI_BIO/status/1927387529214406746)  2025-05-27T15:32Z [----] followers, [---] engagements


"CEO Marc Hertz shared positive interim biomarker data from the first [--] patients in our ongoing Phase 2a study of GRI-0621 in #IdiopathicPulmonaryFibrosis. Check it out here: $GRI #IPF #FibroticDisease https://vimeo.com/1082315630/99c3d54b85 https://vimeo.com/1082315630/99c3d54b85"  
[X Link](https://x.com/GRI_BIO/status/1933155090602320054)  2025-06-12T13:31Z [----] followers, [---] engagements


"Idiopathic Pulmonary Fibrosis is a rare chronic disease marked by abnormal lung scarring that blocks oxygen from reaching the bloodstream. The need for innovation is urgentand at $GRI we're working to make a difference. #IPF #FibroticDisease"  
[X Link](https://x.com/GRI_BIO/status/1934983410268684716)  2025-06-17T14:36Z [----] followers, [---] engagements


"GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) $GRI #NKT #FibroticDisease #IdiopathicPulmonaryFibrosis https://bit.ly/4l96oT7 https://bit.ly/4l96oT7"  
[X Link](https://x.com/GRI_BIO/status/1940045002396017076)  2025-07-01T13:49Z [----] followers, [---] engagements


"We shed light on the #IdiopathicPulmonaryFibrosis patient journey a progressive disease with limited treatment options and a profound impact on daily life. Tune in to hear how we're working to change the future for those affected: $GRI #IPF https://bit.ly/3STtcK4 https://bit.ly/3STtcK4"  
[X Link](https://x.com/GRI_BIO/status/1945472526777307227)  2025-07-16T13:16Z [----] followers, [---] engagements


"GRI Bio Participates in the @investorvirtual Whats Your Story Summer Spotlight On-Demand Conference Access the video here: $GRI #NKT #FibroticDisease #IdiopathicPulmonaryFibrosis https://bit.ly/4lZg5nD https://bit.ly/46nIsGX https://bit.ly/4lZg5nD https://bit.ly/46nIsGX"  
[X Link](https://x.com/GRI_BIO/status/1947658216474611840)  2025-07-22T14:01Z [----] followers, [---] engagements


"GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (IPF) $GRI #NKT #FibroticDisease #IdiopathicPulmonaryFibrosis https://bit.ly/45eLjzV https://bit.ly/45eLjzV"  
[X Link](https://x.com/GRI_BIO/status/1950927318953660550)  2025-07-31T14:31Z [----] followers, [---] engagements


"GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech $GRI #IPF #InflammatoryDisease #FibroticDisease https://bit.ly/4fMbByb https://bit.ly/4fMbByb"  
[X Link](https://x.com/GRI_BIO/status/1955991152739389643)  2025-08-14T13:53Z [----] followers, [---] engagements


"$GRI is joining the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech on August 20th at 2:20pm ET. Hear from CEO Marc Hertz on whats driving $GRIs momentum in fibrotic and inflammatory diseases. Register now: @WebullGlobal https://bit.ly/3Hvo9NL https://bit.ly/3Hvo9NL"  
[X Link](https://x.com/GRI_BIO/status/1956344335533851098)  2025-08-15T13:16Z [----] followers, [---] engagements


"Were looking forward to attending the 9th Annual IPF Summit where well join leading researchers clinicians and industry experts to discuss advancements in #IdiopathicPulmonaryFibrosis. 📅 August [----] 📍 Boston MA Event details: $GRI @HansonWade https://bit.ly/4eXcH9y https://bit.ly/4eXcH9y"  
[X Link](https://x.com/GRI_BIO/status/1957433310184972769)  2025-08-18T13:24Z [----] followers, [---] engagements


"At the heart of our mission is the belief that innovative science can lead to transformative therapies. We're dedicated to changing the lives of patients affected by inflammatory diseases. $GRI #FibroticDisease #IdiopathicPulmonaryFibrosis"  
[X Link](https://x.com/GRI_BIO/status/1959964033269813330)  2025-08-25T13:00Z [----] followers, [---] engagements


"September is #PulmonaryFibrosisMonth Join us in raising awareness supporting patients and advancing research: $GRI #EmbraceYourBreath #NKT #FibroticDisease https://bit.ly/3sstAVM https://bit.ly/3sstAVM"  
[X Link](https://x.com/GRI_BIO/status/1963279592233259155)  2025-09-03T16:35Z [----] followers, [---] engagements


"#DidYouSee: The 6-week efficacy data is in showing promising early results from our Phase 2a study of GRI-0621 in the fight against fibrotic disease. Catch up here: $GRI #FibroticDisease #IdiopathicPulmonaryFibrosis https://bit.ly/45eLjzV https://bit.ly/45eLjzV"  
[X Link](https://x.com/GRI_BIO/status/1965091048343871994)  2025-09-08T16:33Z [----] followers, [---] engagements


"🚨Starting Soon at 3:00 PM ET Dont miss #GRI CEO Marc Hertz presenting live at the H.C. Wainwright 27th Annual Global Investment Conference in New York City Cant attend in person Access the webcast here: #FibroticDisease #IdiopathicPulmonaryFibrosis https://bit.ly/4ncvVLM https://bit.ly/4ncvVLM"  
[X Link](https://x.com/GRI_BIO/status/1965783148362375600)  2025-09-10T14:23Z [----] followers, [---] engagements


"#InCaseYouMissedIt: CEO Marc Hertz presented at the Webull LIVE Biotech & Medtech Investment Webinar Week sharing the companys progress in addressing fibrotic and inflammatory diseases. Watch the full replay here: $GRI #IdiopathicPulmonaryFibrosis https://bit.ly/4pi7xKt https://bit.ly/4pi7xKt"  
[X Link](https://x.com/GRI_BIO/status/1966145714456494453)  2025-09-11T14:24Z [----] followers, [---] engagements


"The 6-week interim analysis pulmonary function data in patients treated with GRI-0621 shows that there has been no decline in FVC over that time said Toby Maher MD PhD Professor of Clinical Medicine @KECKSchool_USC. Learn more: $GRI https://bit.ly/41OaxnT https://bit.ly/41OaxnT"  
[X Link](https://x.com/GRI_BIO/status/1966503364507693511)  2025-09-12T14:05Z [----] followers, [---] engagements


"Happy #WorldHealthDay $VLON is proud to be advancing our innovative platform technology ADAIR with the potential to deter #stimulantabuse. To learn more about our efforts visit our website https://www.vallon-pharma.com/ https://www.vallon-pharma.com/"  
[X Link](https://x.com/GRI_BIO/status/1379852736041222153)  2021-04-07T17:45Z [----] followers, [--] engagements


"40% of people who abuse or misuse prescription stimulants report snorting or injecting them. #StimulantAbuse #AbuseDeterrent $VLON"  
[X Link](https://x.com/GRI_BIO/status/1443584944576466948)  2021-09-30T14:34Z [----] followers, [--] engagements


"We target earlier key steps in the inflammatory cascade to interrupt disease progression. $GRI #NKT #IdiopathicPulmonaryFibrosis #SystemicLupusErythematosus"  
[X Link](https://x.com/GRI_BIO/status/1687561732670070784)  2023-08-04T20:30Z [----] followers, 98.3K engagements


"We are advancing an innovative pipeline of #NKT cell modulators for the treatment of #inflammatory #fibrotic and #autoimmune diseases. $GRI #IdiopathicPulmonaryFibrosis #SystemicLupusErythematosus"  
[X Link](https://x.com/GRI_BIO/status/1699800708244250863)  2023-09-07T15:04Z [----] followers, 40.4K engagements


"Regulating NKT Cells is a selective approach to immunomodulation via resetting the immune response. Learn more here: $GRI #NKT #FibroticDisease #AutoimmuneDisease https://bit.ly/3SJKSYL https://bit.ly/3SJKSYL"  
[X Link](https://x.com/GRI_BIO/status/1838215254758592869)  2024-09-23T13:54Z [----] followers, [---] engagements


"#HappeningTomorrow at 4:00 PM ET Join CEO Marc Hertz for a Virtual Investor Closing Bell Series where hell provide a corporate overview and discuss the companys future business outlook. Register here: $GRI #NKT #FibroticDisease @InvestorVirtual https://bit.ly/41xFDRn https://bit.ly/41xFDRn"  
[X Link](https://x.com/GRI_BIO/status/1866882931630715090)  2024-12-11T16:29Z [----] followers, [---] engagements


"GRI Bios therapies are designed to target the activity of NKT cells which are key regulators earlier in the inflammatory cascade to interrupt disease progression and restore the immune system to homeostasis. $GRI #FibroticDisease #IPF"  
[X Link](https://x.com/GRI_BIO/status/1915055591719944363)  2025-04-23T14:50Z [----] followers, [---] engagements


"Halfway through #Lupus Awareness Month Lets turn this awareness into action. Keep sharing resources having conversations and advocating for those living with lupus. The more we know the more we can do. Learn more: $GRI @LupusOrg #MakeLupusVisible https://bit.ly/3Lk8csv https://bit.ly/3Lk8csv"  
[X Link](https://x.com/GRI_BIO/status/1923389739282915644)  2025-05-16T14:47Z [----] followers, [---] engagements


"#InCaseYouMissedIt: We discussed how our preclinical data reinforces the rationale behind our ongoing Phase 2a study of GRI-0621 evaluating safety tolerability and biomarker impact in #IPF patients. $GRI #FibroticDisease https://vimeo.com/1100359323/523a78bd3c https://vimeo.com/1100359323/523a78bd3c"  
[X Link](https://x.com/GRI_BIO/status/1943637164912160936)  2025-07-11T11:43Z [----] followers, [---] engagements


"GRI Bio CEO Marc Hertz Participates in Virtual Investor What This Means Segment $GRI #NKT #FibroticDisease #IdiopathicPulmonaryFibrosis @InvestorVirtual https://bit.ly/4mqfR8S https://bit.ly/4mqfR8S"  
[X Link](https://x.com/GRI_BIO/status/1950979370903834706)  2025-07-31T17:58Z [----] followers, [---] engagements


"Are you familiar with the symptoms of #IdiopathicPulmonaryFibrosis @PFFORG offers helpful information and resources for those seeking support. Learn more: $GRI #IPF #InflammatoryDisease #FibroticDisease https://bit.ly/4cEkKGS https://bit.ly/4cEkKGS"  
[X Link](https://x.com/GRI_BIO/status/1953827879457837301)  2025-08-08T14:37Z [----] followers, [---] engagements


"GRI Bio reported interim 6-week lung function results from its ongoing Phase 2a study evaluating GRI-0621 for the treatment of #IdiopathicPulmonaryFibrosis. For details: $GRI #IPF #FibroticDisease https://bit.ly/41OaxnT https://bit.ly/41OaxnT"  
[X Link](https://x.com/GRI_BIO/status/1966123264150819092)  2025-09-11T12:54Z [----] followers, [---] engagements


"Marc Hertz PhD CEO of GRI Bio comments on the 6-week interim lung function data from the ongoing Phase 2a study in #IdiopathicPulmonaryFibrosis. The Phase 2a study is fully enrolled and topline data are expected in Q3 [----]. $GRI https://bit.ly/41OaxnT https://bit.ly/41OaxnT"  
[X Link](https://x.com/GRI_BIO/status/1966188784443142353)  2025-09-11T17:15Z [----] followers, [---] engagements


"As we shine a light on #PulmonaryFibrosis lets come together to support patients and their families. Learn how you can make an impact: $GRI #EmbraceYourBreath #NKT #FibroticDisease https://bit.ly/3sstAVM https://bit.ly/3sstAVM"  
[X Link](https://x.com/GRI_BIO/status/1967632019443048795)  2025-09-15T16:50Z [----] followers, [----] engagements


"This #WorldLungDay lets stand together to support lung health and the people fighting pulmonary diseases every day. $GRI #EmbraceYourBreath #NKT #FibroticDisease"  
[X Link](https://x.com/GRI_BIO/status/1971211458676461919)  2025-09-25T13:53Z [----] followers, [---] engagements


"At GRI Bio we aim to intervene earlier in the immune response to help slow disease progression. $GRI #FibroticDisease #IPF"  
[X Link](https://x.com/GRI_BIO/status/1975236380721648117)  2025-10-06T16:27Z [----] followers, [---] engagements


"#IPF is a devastating lung disease 50% of patients lose their lives within [--] years of diagnosis. We are committed to advancing research to target the immune response earlier and bring hope for better outcomes. $GRI #FibroticDisease #IdiopathicPulmonaryFibrosis"  
[X Link](https://x.com/GRI_BIO/status/1975982810985853152)  2025-10-08T17:53Z [----] followers, [----] engagements


"At $GRI we unite expertise in NKT cells immunology and drug development with one mission: to advance science and deliver transformative therapies for patients facing autoimmune diseases. #NKT #IPF #FibrosisDisease"  
[X Link](https://x.com/GRI_BIO/status/1977778117314830773)  2025-10-13T16:47Z [----] followers, [----] engagements


"#IPF is a progressive lung disease that changes lives. Early diagnosis is key to better care and more options for patients and families. Together we can make a difference. $GRI #FibroticDisease #IdiopathicPulmonaryFibrosis"  
[X Link](https://x.com/GRI_BIO/status/1982851045454713014)  2025-10-27T16:45Z [----] followers, [----] engagements


"Were driven to transform care for patients with inflammatory fibrotic and autoimmune diseases. Explore our clinical study in #IdiopathicPulmonaryFibrosis and join us in shaping the future of #IPF treatment. $GRI #IPF #IdiopathicPulmonaryFibrosis https://bit.ly/4iThvhB https://bit.ly/4iThvhB"  
[X Link](https://x.com/GRI_BIO/status/1986112793225863235)  2025-11-05T16:46Z [----] followers, [----] engagements


"#DidYouKnow Idiopathic Pulmonary Fibrosis has a 50% survival rate in the first 2-3 years of diagnosis That percentage drops to 20% after [--] years of diagnosis. Our team is committed to improving treatment options for #IPF. $GRI #FibroticDisease https://bit.ly/44PhbZT https://bit.ly/44PhbZT"  
[X Link](https://x.com/GRI_BIO/status/1891893540688445778)  2025-02-18T16:52Z [----] followers, [---] engagements


"Stay connected with $GRI Bio. Sign up for updates on our research trials and company news: #FibroticDisease #IdiopathicPulmonaryFibrosis https://bit.ly/45GwuVq https://bit.ly/45GwuVq"  
[X Link](https://x.com/GRI_BIO/status/1980317099416330246)  2025-10-20T16:56Z [----] followers, [----] engagements


"#IdiopathicPulmonaryFibrosis causes progressive lung scarring that makes it difficult to breathe and current treatments dont work for everyone. At GRI Bio were working to change that through innovation and science-driven care. $GRI #IPF #FibroticDisease"  
[X Link](https://x.com/GRI_BIO/status/1988620147205054905)  2025-11-12T14:49Z [----] followers, [----] engagements


"At GRI we have a pipeline focused on high-value indications where innovation is urgently needed. Take a look here: $GRI #IPF #FibroticDisease https://bit.ly/3NufOdo https://bit.ly/3NufOdo"  
[X Link](https://x.com/GRI_BIO/status/1991888860930867603)  2025-11-21T15:18Z [----] followers, [----] engagements


"#IPF offers patients no chance of survival without a lung transplant. This is why our work at GRI Bio matters. Were dedicated to developing therapies that have the potential to transform outcomes for patients and families facing this devastating disease. #FibroticDisease"  
[X Link](https://x.com/GRI_BIO/status/1996620554581733604)  2025-12-04T16:40Z [----] followers, [---] engagements


"$GRI's Ph 2a study met its primary & secondary endpoints demonstrating that GRI-0621 was well tolerated over a 12-week treatment period with no drug-related severe or serious adverse events & no increase in GI issues when used with existing treatments. https://bit.ly/3KK9bFg https://bit.ly/3KK9bFg"  
[X Link](https://x.com/GRI_BIO/status/1998867902544384207)  2025-12-10T21:30Z [----] followers, [----] engagements


"Subjects treated with GRI-0621 in the Phase 2a GRI-0621-IPF-02 clinical trial also displayed improvements in serum biomarkers of collagen turnover suggesting fibrosis resolution & induction of an alveolar basement membrane repair mechanism. Details: $GRI https://bit.ly/3KK9bFg https://bit.ly/3KK9bFg"  
[X Link](https://x.com/GRI_BIO/status/1999120802495516902)  2025-12-11T14:15Z [----] followers, [---] engagements


"Marc Hertz PhD Chief Executive Officer of GRI Bio comments on the positive topline data from the Company's Phase 2a Study evaluating GRI-0621 for the treatment of #IdiopathicPulmonaryFibrosis. For more info: $GRI #FibroticDisease https://bit.ly/3KK9bFg https://bit.ly/3KK9bFg"  
[X Link](https://x.com/GRI_BIO/status/1999192578906825115)  2025-12-11T19:00Z [----] followers, [---] engagements


"At GRI Bio were working to intervene earlier in the inflammatory cascade to help slow or interrupt disease progression. $GRI"  
[X Link](https://x.com/GRI_BIO/status/2000979996605620226)  2025-12-16T17:23Z [----] followers, [----] engagements


"#DidYouSee: The data from our Phase 2a study Positive topline results showed GRI-0621 was well tolerated and met primary and secondary endpoints in IPF with improvements in biomarkers suggesting fibrosis resolution and alveolar basement membrane repair. https://bit.ly/48uhTk6 https://bit.ly/48uhTk6"  
[X Link](https://x.com/GRI_BIO/status/2007097357117075493)  2026-01-02T14:31Z [----] followers, [----] engagements


"Marc Hertz PhD CEO of GRI Bio comments on the additional positive data from the Company's Phase 2a study of GRI-0621 for the treatment of #IdiopathicPulmonaryFibrosis. For more info: $GRI #IPF #FibroticDisease https://bit.ly/4sDfXOj https://bit.ly/4sDfXOj"  
[X Link](https://x.com/GRI_BIO/status/2009325555783479581)  2026-01-08T18:05Z [----] followers, [---] engagements


"New immune profiling data from the Phase 2a GRI-0621-IPF-02 clinical trial confirms disease-modifying mechanism and reinforces earlier signals of fibrosis resolution lung repair and improved lung function. $GRI #IdiopathicPulmonaryFibrosis https://bit.ly/4sDfXOj https://bit.ly/4sDfXOj"  
[X Link](https://x.com/GRI_BIO/status/2009637609245381114)  2026-01-09T14:45Z [----] followers, [---] engagements


"#IPF is a devastating disease with only a 50% survival rate meaning [--] out of [--] patients die within just [--] years of diagnosis. This reality drives our mission to develop innovative therapies that offer patients more time and better outcomes. $GRI"  
[X Link](https://x.com/GRI_BIO/status/2012192028164051309)  2026-01-16T15:55Z [----] followers, [---] engagements


"Dont miss the latest news and updates from $GRI. Sign up for email alerts here: #IPF #FibroticDisease https://bit.ly/45GwuVq https://bit.ly/45GwuVq"  
[X Link](https://x.com/GRI_BIO/status/2014018192700584261)  2026-01-21T16:52Z [----] followers, [---] engagements


"GRI Bio Announces Reverse Stock Split https://bit.ly/4qyzNZD https://bit.ly/4qyzNZD"  
[X Link](https://x.com/GRI_BIO/status/2014081502741475745)  2026-01-21T21:03Z [----] followers, [---] engagements


"Our CEO Marc Hertz PhD provides insight to how we are developing #NKT cells for #immuneregulation. Watch the full video here: $GRI #AutoimmuneDisease #InflammatoryDisease #IdiopathicPulmonaryFibrosis #SystemicLupusErythematosus https://bit.ly/3La8yB5 https://bit.ly/3La8yB5"  
[X Link](https://x.com/anyuser/status/1664300545505480704)  2023-06-01T15:59Z [----] followers, 184.4K engagements


"Our CEO Marc Hertz PhD shares his enthusiasm as we move forward with our new corporate branding identity. $GRI #NKT #IdiopathicPulmonaryFibrosis #SystemicLupusErythematosus"  
[X Link](https://x.com/anyuser/status/1668620654743281671)  2023-06-13T14:05Z [----] followers, 690.9K engagements


"GRI Bio Inc. to Participate in the Virtual Investor Summer Spotlight Series. $GRI @InvestorVirtual #NKT #IdiopathicPulmonaryFibrosis #SystemicLupusErythematosus https://bit.ly/3ptXecj https://bit.ly/3ptXecj"  
[X Link](https://x.com/anyuser/status/1676601091625037826)  2023-07-05T14:37Z [----] followers, 831.2K engagements


"GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics Inc. for the Sale of Legacy Asset ADAIR. $GRI https://bit.ly/44mchDb https://bit.ly/44mchDb"  
[X Link](https://x.com/GRI_BIO/status/1694369373266334204)  2023-08-23T15:21Z [----] followers, [---] engagements


"Marc Hertz PhD Chief Executive Officer of GRI Bio comments on the Company's new U.S. composition of matter patent covering novel compound structures. For more info: $GRI https://bit.ly/3NEfRG1 https://bit.ly/3NEfRG1"  
[X Link](https://x.com/GRI_BIO/status/2015898431743467618)  2026-01-26T21:23Z [----] followers, [---] engagements


"Marc Hertz PhD CEO of GRI Bio comments on the compelling new Phase 2a gene expression data demonstrating improvements in key drivers of fibrosis and lung repair in #IdiopathicPulmonaryFibrosis. Read more: $GRI #IPF https://bit.ly/4q6n4fB https://bit.ly/4q6n4fB"  
[X Link](https://x.com/GRI_BIO/status/2016575864847094271)  2026-01-28T18:15Z [----] followers, [---] engagements


"GRI Bio CEO Marc Hertz PhD will participate in the Corporate Connect Webinar Series hosted by Webull Financial on Wednesday February 11th at 1:00 PM EST. For presentation details: $GRI https://bit.ly/3MdrRxV https://bit.ly/3MdrRxV"  
[X Link](https://x.com/GRI_BIO/status/2019415945739944315)  2026-02-05T14:20Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing